Cellectar Biosciences CLRB

NASDAQ CLRB

$2.59 -0.03 (-1.15%)

At close: Aug 20, 2026 · 4:00 PM EDT

Cellectar Biosciences (CLRB) Debt Ratio (2010 - 2020)

Cellectar Biosciences (CLRB) posted Debt Ratio of 0.01 for Q3 2020, up 15.25% sequentially from 0.01 in Q2 2020.

Cellectar Biosciences (CLRB) Debt Ratio (2010 - 2020) Analysis & Trends

Cellectar Biosciences has reported Debt Ratio for 8 years, with the latest figure at 0.01 in Q3 2020.

Quarterly Debt Ratio changed N/A year-over-year to 0.01 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.01 (changed N/A YoY) and the FY2015 annual result came in at 0.01, down 53.63% from the prior year.
Debt Ratio grew to 0.01 in Q3 2020 per CLRB's latest filing, from 0.01 in the prior quarter.
Over five years, Debt Ratio peaked at 0.01 in Q3 2020 and troughed at 0.0 in Q1 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	0.05
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	0.26
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	0.47
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	0.03
10	Cellectar Biosciences	6.63 Mn	6.63 Mn	-	-

Historic Data

Download Data

Date	Value
Sep 30, 2020	0.01
Jun 30, 2020	0.01
Mar 31, 2016	0.00
Dec 31, 2015	0.01
Sep 30, 2015	0.02
Jun 30, 2015	0.02
Mar 31, 2015	0.02
Dec 31, 2014	0.02
Sep 30, 2014	0.02
Jun 30, 2014	0.07
Mar 31, 2014	0.06
Dec 31, 2013	0.07
Sep 30, 2013	0.05
Jun 30, 2013	0.04
Mar 31, 2013	0.03
Dec 31, 2012	0.04
Sep 30, 2012	0.04
Jun 30, 2012	0.04
Mar 31, 2012	0.05
Dec 31, 2011	0.04

Cellectar Biosciences (CLRB)

NASDAQ: CLRB

$2.59 ▼ -0.03 (-1.15%)

Aug 20, 2026 · 4:00 PM EDT